Old Web
English
Sign In
Acemap
>
authorDetail
>
Marcos Pedrosa
Marcos Pedrosa
Novartis
Medicine
Internal medicine
Liver biopsy
Nonalcoholic fatty liver disease
Physical therapy
3
Papers
44
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) and Associated Risk Factors – A Targeted Literature Review
2021
Jean-François Dufour
Roger Scherer
Maria-Magdalena Balp
S.J. Mckenna
Nico Janssens
Patricia Lopez
Marcos Pedrosa
Show All
Source
Cite
Save
Citations (3)
Development of a novel machine learning model to predict presence of nonalcoholic steatohepatitis.
2021
Journal of the American Medical Informatics Association
Matt Docherty
Stephane A. Regnier
Gorana Capkun
Maria-Magdalena Balp
Qin Ye
Nico Janssens
Andreas Tietz
Jürgen Löffler
J. Cai
Marcos Pedrosa
Jörn M. Schattenberg
Show All
Source
Cite
Save
Citations (3)
A randomized, double-blind, multicenter, phase 2b study to evaluate the safety and efficacy of a combination of tropifexor and cenicriviroc in patients with nonalcoholic steatohepatitis and liver fibrosis: Study design of the TANDEM trial.
2019
Contemporary Clinical Trials
Marcos Pedrosa
Star Seyedkazemi
Sven Francque
Arun J. Sanyal
Mary E. Rinella
Michael Charlton
Rohit Loomba
Vlad Ratziu
Jossy Kochuparampil
Laurent Fischer
Sujata Vaidyanathan
Quentin M. Anstee
Show All
Source
Cite
Save
Citations (38)
1